Advanced search
Publication Cover
Vascular Health and Risk Management Volume 13, 2017 - Issue
Submit an article Journal homepage
54
Views
9
CrossRef citations to date
0
Altmetric
Original Research

DPP-4 inhibitor treatment: β-cell response but not HbA1c reduction is dependent on the duration of diabetes

Plamen Kozlovski1 Novartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
,
Vaishali Bhosekar2 Novartis Healthcare Private Limited, Hyderabad, India
&
James E Foley3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Pages 123-126 | Published online: 31 Mar 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.